Tag: polycystic ovary syndrome

Bodyweight gain and anticonvulsants: a comparative review

This 2001 review by Jallon and Picard examines the prevalence, mechanisms, and clinical implications of weight gain associated with anticonvulsant therapy. The authors highlight that medications such as valproic acid, carbamazepine, vigabatrin, and gabapentin are frequently linked to significant weight gain in patients with epilepsy, affecting both pediatric and adult

Read More »

Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest-Post-Test Explanatory Study

The study “Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome,” published in Nutrients (2021), investigated the effects of berberine phospholipid supplementation on insulin sensitivity and metabolic and hormonal disturbances in women with polycystic ovary syndrome (PCOS). The results indicated

Read More »

Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features

The study examines the role of alpha-lipoic acid (ALA) in glucose metabolism, emphasizing its antioxidant properties, ability to enhance insulin sensitivity and secretion, and therapeutic potential in conditions like diabetic polyneuropathy, metabolic syndrome, polycystic ovary syndrome (PCOS), and obesity. ALA is widely prescribed for diabetic neuropathy due to its benefits

Read More »